Bayer HealthCare Pharmaceuticals, Inc.

Open-label, multi-center, two-stage, age stratified, pharmacokinetic, safety, and efficacy study in children 2 month to < 2 years of age undergoing Magnevist Injection enhanced MRI - Magnevist pediatric pharmacokinetic